WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that impose a duty on generic drug makers to either change their labeling in violation of federal law or pull the ...Read More »
WASHINGTON – Deciding where the preemptive effect of federal rules governing drug manufacturing ends and states’ ability to impose liability on drug makers begins has never been an easy task — not even for the justices of the U.S. Supreme ...Read More »
The past year featured a flurry of activity on the personal injury and tort scene, with several new drug and device developments, significant U.S. Supreme Court rulings and some staggering verdicts. Here’s a wrap-up of the highlights of personal injury ...
Tagged with: asbestos Botox brain fog brain injury class action erectile dysfunction failure to warn frakking hair loss health risks hepatitis implied preemption mesothelioma natural gas nuisance pelvic mesh Propecia property devaluation Proscar technology tort claims tort climate Twiqbal U.S. Supreme CourtRead More »